NNIH funding for phased clinical trials represents <3.5% of total spending

The U.S. National Institutes of Health (NIH) contributed $8.1 billion in project funding for phased clinical trials involving drugs approved by the FDA from 2010-2019, according to a new study from Bentley University's Center for Integration of Science and Industry.

Related Keywords

Matthew Jackson ,Megan Craig ,Edward Zhou ,Health Forum ,National Pharmaceutical Council ,Us National Institutes Of Health ,Bentley University Center ,National Biomedical Research Foundation ,Bentley University ,Clinical Translational Science Awards ,National Biomedical Research ,Drugs ,Research ,Students ,